Logo image of VMD.CA

Viemed Healthcare Inc (VMD.CA) Stock Fundamental Analysis

TSX:VMD - Toronto Stock Exchange - CA92663R1055 - Common Stock - Currency: CAD

10.45  +0.29 (+2.85%)

Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to VMD. VMD was compared to 15 industry peers in the Health Care Providers & Services industry. Both the health and profitability get an excellent rating, making VMD a very profitable company, without any liquidiy or solvency issues. VMD is not priced too expensively while it is growing strongly. Keep and eye on this one! With these ratings, VMD could be worth investigating further for growth and quality investing!.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

VMD had positive earnings in the past year.
VMD had a positive operating cash flow in the past year.
VMD had positive earnings in each of the past 5 years.
In the past 5 years VMD always reported a positive cash flow from operatings.
VMD.CA Yearly Net Income VS EBIT VS OCF VS FCFVMD.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M

1.2 Ratios

The Return On Assets of VMD (6.16%) is better than 95.24% of its industry peers.
With a decent Return On Equity value of 8.47%, VMD is doing good in the industry, outperforming 76.19% of the companies in the same industry.
VMD has a better Return On Invested Capital (7.90%) than 90.48% of its industry peers.
The Average Return On Invested Capital over the past 3 years for VMD is above the industry average of 8.15%.
Industry RankSector Rank
ROA 6.16%
ROE 8.47%
ROIC 7.9%
ROA(3y)13.66%
ROA(5y)13.79%
ROE(3y)18.18%
ROE(5y)20.63%
ROIC(3y)11.36%
ROIC(5y)13.33%
VMD.CA Yearly ROA, ROE, ROICVMD.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 10 20 30

1.3 Margins

VMD has a better Profit Margin (5.42%) than 90.48% of its industry peers.
In the last couple of years the Profit Margin of VMD has declined.
The Operating Margin of VMD (7.73%) is better than 90.48% of its industry peers.
VMD's Operating Margin has declined in the last couple of years.
With an excellent Gross Margin value of 61.00%, VMD belongs to the best of the industry, outperforming 90.48% of the companies in the same industry.
In the last couple of years the Gross Margin of VMD has declined.
Industry RankSector Rank
OM 7.73%
PM (TTM) 5.42%
GM 61%
OM growth 3Y-18.23%
OM growth 5Y-20.06%
PM growth 3Y-24.99%
PM growth 5Y-23.88%
GM growth 3Y-4.35%
GM growth 5Y-3.72%
VMD.CA Yearly Profit, Operating, Gross MarginsVMD.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 20 40 60

More info and screens

7

2. Health

2.1 Basic Checks

VMD has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for VMD has been reduced compared to 1 year ago.
Compared to 1 year ago, VMD has an improved debt to assets ratio.
VMD.CA Yearly Shares OutstandingVMD.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M
VMD.CA Yearly Total Debt VS Total AssetsVMD.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M

2.2 Solvency

VMD has an Altman-Z score of 6.66. This indicates that VMD is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.66, VMD belongs to the top of the industry, outperforming 90.48% of the companies in the same industry.
VMD has a debt to FCF ratio of 0.65. This is a very positive value and a sign of high solvency as it would only need 0.65 years to pay back of all of its debts.
VMD has a Debt to FCF ratio of 0.65. This is amongst the best in the industry. VMD outperforms 100.00% of its industry peers.
VMD has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
VMD has a better Debt to Equity ratio (0.08) than 95.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.65
Altman-Z 6.66
ROIC/WACC0.94
WACC8.43%
VMD.CA Yearly LT Debt VS Equity VS FCFVMD.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 1.14 indicates that VMD should not have too much problems paying its short term obligations.
The Current ratio of VMD (1.14) is comparable to the rest of the industry.
A Quick Ratio of 0.99 indicates that VMD may have some problems paying its short term obligations.
VMD's Quick ratio of 0.99 is in line compared to the rest of the industry. VMD outperforms 52.38% of its industry peers.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 0.99
VMD.CA Yearly Current Assets VS Current LiabilitesVMD.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M

More info and screens

9

3. Growth

3.1 Past

VMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.05%, which is quite impressive.
Measured over the past years, VMD shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.17% on average per year.
VMD shows a strong growth in Revenue. In the last year, the Revenue has grown by 27.38%.
The Revenue has been growing by 24.23% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)21.05%
EPS 3Y-13.28%
EPS 5Y-6.17%
EPS Q2Q%133.33%
Revenue 1Y (TTM)27.38%
Revenue growth 3Y20.01%
Revenue growth 5Y24.23%
Sales Q2Q%38.14%

3.2 Future

VMD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 54.71% yearly.
The Revenue is expected to grow by 21.44% on average over the next years. This is a very strong growth
EPS Next Y75.07%
EPS Next 2Y65.14%
EPS Next 3Y54.71%
EPS Next 5YN/A
Revenue Next Year31.41%
Revenue Next 2Y25.78%
Revenue Next 3Y21.44%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
VMD.CA Yearly Revenue VS EstimatesVMD.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
VMD.CA Yearly EPS VS EstimatesVMD.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 34.83, VMD can be considered very expensive at the moment.
Based on the Price/Earnings ratio, VMD is valued cheaply inside the industry as 80.95% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of VMD to the average of the S&P500 Index (26.34), we can say VMD is valued slightly more expensively.
VMD is valuated rather expensively with a Price/Forward Earnings ratio of 19.28.
Based on the Price/Forward Earnings ratio, VMD is valued cheaper than 85.71% of the companies in the same industry.
VMD's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.03.
Industry RankSector Rank
PE 34.83
Fwd PE 19.28
VMD.CA Price Earnings VS Forward Price EarningsVMD.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

76.19% of the companies in the same industry are more expensive than VMD, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of VMD is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 19.11
EV/EBITDA 9.09
VMD.CA Per share dataVMD.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

VMD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
VMD has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as VMD's earnings are expected to grow with 54.71% in the coming years.
PEG (NY)0.46
PEG (5Y)N/A
EPS Next 2Y65.14%
EPS Next 3Y54.71%

More info and screens

0

5. Dividend

5.1 Amount

VMD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Viemed Healthcare Inc

TSX:VMD (12/21/2023, 7:00:00 PM)

10.45

+0.29 (+2.85%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners31.13%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap402.32M
Analysts80
Price Target19.25 (84.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.17%
Min EPS beat(2)-18.46%
Max EPS beat(2)18.81%
EPS beat(4)2
Avg EPS beat(4)8.43%
Min EPS beat(4)-18.46%
Max EPS beat(4)48.51%
EPS beat(8)3
Avg EPS beat(8)-0.69%
EPS beat(12)5
Avg EPS beat(12)22.7%
EPS beat(16)7
Avg EPS beat(16)24.4%
Revenue beat(2)1
Avg Revenue beat(2)1.01%
Min Revenue beat(2)-1.19%
Max Revenue beat(2)3.2%
Revenue beat(4)2
Avg Revenue beat(4)0.6%
Min Revenue beat(4)-1.49%
Max Revenue beat(4)3.2%
Revenue beat(8)6
Avg Revenue beat(8)1.73%
Revenue beat(12)8
Avg Revenue beat(12)1.84%
Revenue beat(16)10
Avg Revenue beat(16)-1.12%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-18.18%
EPS NY rev (1m)-5.45%
EPS NY rev (3m)-5.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)96920.2%
Revenue NY rev (1m)-1.27%
Revenue NY rev (3m)-1.27%
Valuation
Industry RankSector Rank
PE 34.83
Fwd PE 19.28
P/S 1.79
P/FCF 19.11
P/OCF 7.66
P/B 2.79
P/tB 3.87
EV/EBITDA 9.09
EPS(TTM)0.3
EY2.87%
EPS(NY)0.54
Fwd EY5.19%
FCF(TTM)0.55
FCFY5.23%
OCF(TTM)1.36
OCFY13.05%
SpS5.84
BVpS3.74
TBVpS2.7
PEG (NY)0.46
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.16%
ROE 8.47%
ROCE 11.15%
ROIC 7.9%
ROICexc 8.64%
ROICexgc 12.03%
OM 7.73%
PM (TTM) 5.42%
GM 61%
FCFM 9.36%
ROA(3y)13.66%
ROA(5y)13.79%
ROE(3y)18.18%
ROE(5y)20.63%
ROIC(3y)11.36%
ROIC(5y)13.33%
ROICexc(3y)16.33%
ROICexc(5y)18.87%
ROICexgc(3y)16.33%
ROICexgc(5y)18.87%
ROCE(3y)16.03%
ROCE(5y)18.81%
ROICexcg growth 3Y-20.42%
ROICexcg growth 5Y-25.33%
ROICexc growth 3Y-20.42%
ROICexc growth 5Y-25.33%
OM growth 3Y-18.23%
OM growth 5Y-20.06%
PM growth 3Y-24.99%
PM growth 5Y-23.88%
GM growth 3Y-4.35%
GM growth 5Y-3.72%
F-Score4
Asset Turnover1.14
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.65
Debt/EBITDA 0.25
Cap/Depr 116.84%
Cap/Sales 13.98%
Interest Coverage 24.31
Cash Conversion 118.48%
Profit Quality 172.53%
Current Ratio 1.14
Quick Ratio 0.99
Altman-Z 6.66
F-Score4
WACC8.43%
ROIC/WACC0.94
Cap/Depr(3y)152.39%
Cap/Depr(5y)165.61%
Cap/Sales(3y)14.43%
Cap/Sales(5y)13.89%
Profit Quality(3y)59.5%
Profit Quality(5y)83.35%
High Growth Momentum
Growth
EPS 1Y (TTM)21.05%
EPS 3Y-13.28%
EPS 5Y-6.17%
EPS Q2Q%133.33%
EPS Next Y75.07%
EPS Next 2Y65.14%
EPS Next 3Y54.71%
EPS Next 5YN/A
Revenue 1Y (TTM)27.38%
Revenue growth 3Y20.01%
Revenue growth 5Y24.23%
Sales Q2Q%38.14%
Revenue Next Year31.41%
Revenue Next 2Y25.78%
Revenue Next 3Y21.44%
Revenue Next 5YN/A
EBIT growth 1Y35.22%
EBIT growth 3Y-1.87%
EBIT growth 5Y-0.68%
EBIT Next Year275.8%
EBIT Next 3Y76.08%
EBIT Next 5YN/A
FCF growth 1Y829.24%
FCF growth 3Y-5.24%
FCF growth 5Y-9.57%
OCF growth 1Y101.83%
OCF growth 3Y13.28%
OCF growth 5Y18.21%